Condition:   Rheumatoid Arthritis
Interventions:   Drug: Tofacitinib (Xeljanz);   Drug: Etanercept, other Biologics, Disease-modifying antirheumatic drugs (DMARDs), etc
Sponsors:   Pfizer;   Pfizer
Enrolling by invitation - verified August 2013